Braxia Scientific Leadership Receives Funding From Canadian Government To Study Ketamine Therapy

Braxia Scientific Leadership Receives Funding From Canadian Government To Study Ketamine Therapy

Braxia Scientific Corp BRAX BRAXF, a Toronto-based company that provides ketamine-assisted therapy announced that CEO Dr. Roger McIntyre and Chief Medical and Scientific Officer Dr. Josh Rosenblat have received funding of CA$918.000 (approximately $732.000) from the Canadian Institutes of Health Research.

The grant will be used for a clinical trial that will assess the effectiveness of intravenous ketamine in combination with Internet-based cognitive behavioural therapy in the treatment of suicidality in persons with depression.

According to Health Canada, suicide is the second leading cause of death in children and young adults and the ninth cause of death in the country.

The study will measure the effectiveness of combining both therapies against the use of Internet-based cognitive behavioural therapy on its own.

The trial will be held at one of Braxia’s clinics in Mississauga, Ontario, operated by the Canadian Rapid Treatment Centre of Excellence, a subsidiary of the company.

"The results of this study will have tremendous implications for public health and will inform the feasibility of integrating virtual health platforms with IV ketamine, which is a research and development priority for Braxia Scientific," McIntyre said.

Photo by LinkedIn Sales Solutions on Unsplash

Posted In: KetaminepsychedelicsCannabisPenny StocksHealth CarePsychologyMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.